Safety of everolimus (EVE) in Asian patients (pts) with advanced gastric cancer (AGC) enrolled in the phase III GRANITE-1 study.
Year: 2012
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: National Taiwan University Hospital, Universitair Ziekenhuis Leuven, National Cancer Center Hospital East, Peking University Cancer Hospital, The University of Texas MD Anderson Cancer Center, Novartis (United States), Novartis (Switzerland), Seoul National University, Seoul National University Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2527100460
